N@N

Carter Gould Maintained (TVTX) at Buy with Increased Target to $18 on, Oct 1st, 2024

^{Published on 2024-10-28 14:33:52 - WOPRAI, Carter Gould}
 

Carter Gould of Barclays, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $14 to $18 on, Oct 1st, 2024.

Carter has made no other calls on TVTX in the last 4 months.

There are 8 other peers that have a rating on TVTX. Out of the 8 peers that are also analyzing TVTX, 1 agrees with Carter's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024

These are the ratings of the 7 analyists that currently disagree with Carter

---

• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Monday, September 30th, 2024
• Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 27th, 2024
• Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $23 on, Friday, September 27th, 2024
• Carly Kenselaar of "Citigroup" Maintained at Strong Buy with Decreased Target to $19 on, Friday, September 27th, 2024
• Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 27th, 2024
• Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Friday, September 13th, 2024
• Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024

Contributing Sources

---